Latin America Strategy
CARE9’s Latin America operations focus on transforming healthcare delivery across major economies through vertically integrated solutions combining manufacturing, diagnostics, specialty care, and digital platforms. Our strategy aligns with national health priorities, MERCOSUR trade agreements, and PAHO/WHO frameworks.
Brazil: Flagship Market & Regional Hub
Market Overview
Brazil represents CARE9’s largest Latin American market with 215+ million population, well-developed healthcare infrastructure, and strategic geographic positioning as the regional hub for South American operations.
Strategic Partnerships
Federal Ministry of Health (Ministério da Saúde)
- Unified Health System (SUS - Sistema Único de Saúde) integration
- National health programs alignment
- Regulatory and licensing coordination
- Public-private partnership frameworks
ANVISA (National Health Regulatory Agency)
- Pharmaceutical registration and approval
- Manufacturing facility inspection and certification
- Medical device approval pathways
- Pharmacovigilance oversight
ABEFARMA (Brazilian Pharmaceutical Manufacturers Association)
- Industry partnerships and market access
- Supply chain integration
- Workforce development collaboration
State Health Secretariats
- Regional hospital network partnerships
- State-level SUS integration
- Public procurement participation
- Healthcare infrastructure development
Flagship Initiatives
1. Pharmaceutical Manufacturing Hub - São Paulo Complex
Investment: USD 250-300M
Facility Specifications:
- Manufacturing Capacity: 500M+ pharmaceutical units annually
- Specialization: Oncology injectables, critical care, specialty pharmaceuticals
- Certifications: ANVISA approval, WHO-GMP compliance, ISO certifications
- Technology: Automated filling lines, lyophilization, sterile compounding
Product Portfolio:
- Oncology injectables (chemotherapy agents, biologics)
- Critical care pharmaceuticals (IV fluids, antibiotics, antivirals)
- Specialty medicines (rheumatology, gastroenterology)
- Generic formulations for SUS supply
Production Targets:
- 120,000+ patients served annually
- USD 500M+ annual production value
- 70% SUS market supply capability
- Export readiness to MERCOSUR and Latin America
Workforce:
- 1500+ direct manufacturing jobs
- 5000+ indirect supply chain positions
- Local hiring and skills development programs
- CARE9 Academy for pharmaceutical workforce training
2. Specialty Hospital Network
Investment: USD 180-220M
Flagship Hospital - Rio de Janeiro:
- Beds: 250 tertiary care beds
- Focus: Oncology, cardiology, orthopedic surgery
- Certifications: ONA (National Accreditation Organization) Level 3
- Services: Advanced diagnostics, surgical suites, ICU beds, telemedicine
Secondary Facilities:
- São Paulo: 180-bed specialty hospital
- Belo Horizonte: 120-bed regional center
- Salvador: 100-bed teaching hospital
- Brasília: 80-bed government relations center
Clinical Services:
- Oncology: Chemotherapy, radiation therapy, surgical oncology
- Cardiology: Catheterization labs, cardiac surgery, electrophysiology
- Orthopedics: Joint replacement, spine surgery, trauma care
- Diagnostics: Advanced imaging (PET-CT, MRI, CT)
- Telemedicine: Specialist consultations across Brazil
SUS Integration:
- Public and private insurance partnerships
- Performance-based reimbursement models
- Quality outcome tracking
- Patient safety protocols aligned with SUS standards
3. Diagnostics Network - Central Laboratory Model
Investment: USD 80-100M
Hub Locations:
- São Paulo: Central reference laboratory and hub
- Rio de Janeiro: Regional hub and reference center
- Salvador: Northeast regional hub
- Brasília: Central-West hub
Spoke Sites: 30+ locations across major cities
Service Capabilities:
- Molecular Diagnostics: PCR, qPCR, NGS, genetic testing
- Histopathology: Automated processing, digital pathology
- Hematology & Biochemistry: Advanced analyzers and LIS integration
- Immunology: Serology, flow cytometry, immunoassays
- Microbiology: Bacterial, fungal, parasitic testing
- Tele-pathology: Remote specialist consultations
SUS Integration:
- Public hospital lab network integration
- Performance standards and quality assurance
- Affordable pricing aligned with SUS budgets
- Training programs for public sector technicians
4. CARE9 HIMS Deployment - Digital Health Backbone
Investment: USD 60-80M
Current & Target Deployments:
- 150+ hospitals (SUS public and private institutions)
- 500+ clinics and primary care centers
- 1000+ pharmacies in pharmaceutical supply chain
- 10,000+ healthcare professionals trained
Capabilities:
- Electronic health records (EHR) with Portuguese localization
- Prescription management and drug interaction checking
- Laboratory integration with diagnostic network
- Imaging and diagnostics integration
- Billing and insurance claim processing
- CARE9 Verified® traceability throughout care journey
Interoperability:
- HL7/FHIR standards compliance
- NDHM (Brazilian Health Information System) integration
- SUS interoperability frameworks
- Insurance system connectivity
Impact:
- 30%+ operational efficiency improvement
- 40%+ reduction in medication errors
- 50%+ faster diagnostic turnaround time
- Enhanced patient safety and quality metrics
Colombia: Secondary Hub & Andean Gateway
Strategic Market Position
Colombia serves as the gateway to Andean markets (Peru, Ecuador, Bolivia) and Central America with 52+ million population and growing healthcare infrastructure investment.
Key Initiatives
1. Bogotá Specialty Hospital
Investment: USD 100-120M
Specifications:
- Beds: 150 tertiary care beds
- Focus: Oncology, cardiology, general surgery
- Certifications: Colombian health ministry approval, international standards
- Services: Advanced diagnostics, specialty surgery, telemedicine
Regional Hub Functions:
- Andean regional command center
- Clinical training academy
- Regulatory affairs center for Colombia/Andean region
- HIMS deployment and support hub
2. Pharmaceutical Manufacturing & Distribution
Investment: USD 80-100M
Medellín Manufacturing Facility:
- WHO-GMP certified pharmaceutical manufacturing
- Critical care and specialty pharmaceutical production
- Local SUS-equivalent (EPS) supply integration
- INVIMA regulatory approval
Distribution Network:
- Central warehouse in Bogotá
- Regional distribution hubs (Medellín, Cali, Barranquilla)
- 500+ pharmacy network integration
- Colombia, Ecuador, Peru supply coverage
Market Impact:
- USD 150M+ annual pharmaceutical sales (2026 projection)
- 60% critical medicines market penetration
- 800+ manufacturing and supply chain jobs
- Import substitution in key therapeutic areas
3. HIMS Deployment Across Colombia
- 80+ hospitals across public and private systems
- 150+ clinics and diagnostic centers
- 400+ pharmacies integrated network
- 2000+ healthcare professionals trained
Regional Impact:
- Telemedicine platform connecting Colombia-Peru-Ecuador
- Shared diagnostics network with CARE9 laboratories
- Unified pharmaceutical supply chain
- Clinical training programs across Andean region
Peru: Andean Market Entry & Growth Platform
Strategic Market Position
Peru represents the gateway to Andean markets and a growing healthcare opportunity with 34+ million population and increasing government healthcare investment.
Key Initiatives
1. Lima Specialty Care Center
Investment: USD 60-80M
Facility Overview:
- Beds: 100 specialty care beds
- Focus: Oncology, diagnostic imaging, telemedicine hub
- Certifications: MINSA (Ministry of Health) approval
- Services: Advanced diagnostics, specialty consultations, telemedicine
Functions:
- CARE9’s Peru headquarters and regional office
- Andean telemedicine hub (Peru, Ecuador, Bolivia)
- Diagnostic imaging center (CT, MRI, ultrasound)
- Clinical training and capacity building
2. Pharmaceutical Supply Chain & Distribution
Investment: USD 40-60M
Lima Distribution Center:
- Central pharmaceutical warehouse
- Quality assurance and import compliance
- DIGEMID (regulatory authority) coordination
- Distribution to 200+ healthcare facilities
Service Scope:
- Pharmaceutical supply chain management
- Critical care medicines distribution
- Specialty pharmaceutical supply
- Oncology agent distribution and handling
Market Access:
- MINSA (Ministry of Health) supply partnership
- SIS (Health Insurance) system integration
- EPS (Private Insurance) network participation
- Regional distribution to Ecuador and Bolivia
3. Diagnostics Network Expansion
- 15+ diagnostic centers across Peru
- Molecular diagnostics and specialized testing
- Tele-pathology consultations
- Medical training partnerships
4. HIMS Implementation
- 50+ hospitals across public and private systems
- 100+ clinics and health posts
- 200+ pharmacies network
- 1000+ healthcare professionals trained
Pan-Latin America Regional Integration
MERCOSUR Framework
Trade Integration:
- MERCOSUR pharmaceutical trade agreements
- Tariff harmonization and market access
- Regulatory mutual recognition protocols
- Cross-border telemedicine frameworks
Regional Supply Chain:
- Integrated manufacturing across Brazil, Colombia, Peru
- Regional pharmaceutical distribution network
- Shared diagnostic reference laboratories
- Cross-country telemedicine specialist network
Andean Community (CAN) Alignment
Countries: Colombia, Peru, Ecuador, Bolivia
Integration Strategy:
- Harmonized regulatory standards
- Unified pharmaceutical supply chain
- Regional telemedicine platform
- Shared training and capacity building programs
Market Reach:
- 130+ million population coverage
- 250+ healthcare facilities in network
- 40,000+ healthcare professionals trained
- 2M+ patients served annually
Regulatory Framework & Compliance
National Regulatory Authorities
Brazil:
- ANVISA (National Health Regulatory Agency)
- INMETRO (National Metrology Institute)
- State health secretariats
Colombia:
- INVIMA (National Institute for Food and Drug Surveillance)
- Ministry of Health and Social Protection
- Departmental health authorities
Peru:
- DIGEMID (General Directorate of Medicines, Inputs, and Drugs)
- Ministry of Health
- Regional health authorities
Compliance Standards
Quality & Safety:
- Good Manufacturing Practice (GMP) - WHO standards
- Good Distribution Practice (GDP)
- Good Clinical Practice (GCP)
- ISO 9001, ISO 13485, ISO 27001 certifications
Healthcare Operations:
- National accreditation standards (ONA-Brazil, Colombia, Peru)
- Patient safety protocols
- Infection control standards
- Electronic health record standards
Data Security:
- LGPD (Brazil - Lei Geral de Proteção de Dados)
- National healthcare data standards
- Health information confidentiality requirements
- Telemedicine regulation compliance
Strategic Partnerships
Government & Health Systems
Ministry-Level Partnerships:
- National health ministry collaborations
- Public hospital network partnerships
- National pharmaceutical procurement programs
- Healthcare workforce development
Healthcare Institutions:
- Major hospital chains and health networks
- Medical universities and teaching hospitals
- Private insurance networks (EPS)
- Diagnostic laboratory associations
Financial & Development Partners
Development Finance Institutions:
- Inter-American Development Bank (IDB)
- CAF (Latin American Development Bank)
- Multilateral Investment Fund (MIF)
- BNDES (Brazil National Development Bank)
Impact Investors:
- Healthcare-focused private equity
- Impact and ESG-aligned funds
- Infrastructure funds
- Blended finance providers
Market Penetration Roadmap
Phase 1 (2024-2025)
- Brazil manufacturing commissioning
- Rio de Janeiro hospital operational launch
- 50+ HIMS deployments in Brazil
- Colombia Bogotá facility ground-breaking
Phase 2 (2025-2026)
- Brazil diagnostics network expansion
- Colombia manufacturing operational
- Peru Lima specialty center launch
- 200+ cumulative hospital partnerships
- Regional telemedicine network launch
Phase 3 (2026-2028)
- MERCOSUR-wide integration operational
- Andean regional command centers established
- 350+ hospitals in network
- USD 1B+ cumulative investment
- 50,000+ healthcare professionals trained
ESG Commitments in Latin America
Environmental
- Solar and renewable energy powered facilities
- Water conservation and treatment systems
- Biomedical waste management programs
- Sustainable pharmaceutical packaging
- Amazon rainforest conservation initiatives
Social
- 85%+ local hiring targets
- Healthcare worker training academies
- Women in leadership programs (40%+ target)
- Community health initiatives
- Indigenous healthcare access programs
- Patient safety and quality improvement
Governance
- Transparent procurement processes
- Anti-corruption and anti-bribery compliance
- Ethical clinical research practices
- Stakeholder engagement and community involvement
- Indigenous and minority rights respect
Competitive Advantages
Regional Manufacturing Hub
- Brazil pharmaceutical manufacturing cost advantages
- MERCOSUR trade agreement benefits
- Unified supply chain across South America
- Local content and job creation
Clinical Excellence
- Specialty hospitals meeting international standards
- Advanced diagnostic infrastructure
- Telemedicine connecting region
- Oncology and cardiology expertise
Digital Innovation
- CARE9 HIMS adapted for Latin American markets
- Portuguese and Spanish language support
- Integration with regional health systems
- Advanced analytics for population health
Workforce Development
- CARE9 Academy training regional healthcare professionals
- Specialty certifications and continuing education
- Leadership development programs
- Research and innovation partnerships
Contact & Partnership Inquiries
Latin America Regional Office: São Paulo, Brazil Email: latam@care9.com Brazil Operations: brasil@care9.com Colombia & Andean: colombia@care9.com Business Development: partnerships@care9.com
CARE9: Transforming Healthcare. Building Sovereignty. Serving Communities.